Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

JP:4565 Stock Latest News

Company AnnouncementsNxera Pharma advances APAC expansion and partnered pipeline with new deals and milestones2d ago

Company AnnouncementsNxera Pharma Returns to Profit and Confirms Full-Year Outlook2d ago
Pre-EarningsSOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?4d ago
Company AnnouncementsNxera Pharma Licenses Idorsia’s Fabry Drug Lucerastat for Key Asia Pacific Markets4d ago
Company AnnouncementsNxera Pharma Seeks South Korean Approval for DMD Drug Vamorolone1w ago

Nxera Pharma Ties Executive Stock Options to Aggressive Long-Term Share Price Hurdles

Company AnnouncementsNxera Pharma Ties Executive Stock Options to Aggressive Long-Term Share Price Hurdles1w ago

Company AnnouncementsNxera Strikes Synmosa Deal to Expand Insomnia Drug QUVIVIQ Across Asia-Pacific2w ago

Company AnnouncementsNxera Pharma Gains $8.6 Million Milestone as Lilly-Backed Sleep Disorder Pipeline Advances1M ago

Company AnnouncementsNxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug2M ago
Company AnnouncementsSosei Group Earnings Call Signals Profitable Growth2M ago
Company AnnouncementsNxera Pharma Builds APAC Footprint and Books Milestone Windfall in Q2 20262M ago
Company AnnouncementsNxera Pharma Swings to Profit on Revenue Jump, Keeps 2026 Outlook Intact2M ago

Nxera Pharma Secures Fourth AbbVie Milestone in Neurology Collaboration

Company AnnouncementsNxera Pharma Secures Fourth AbbVie Milestone in Neurology Collaboration4M ago

Company AnnouncementsNxera Pharma Joins OpenFold AI Consortium to Boost GPCR Drug Discovery4M ago

Company AnnouncementsNxera Wins Fast-Track and Orphan Status in Korea for Duchenne Drug Vamorolone5M ago

Company AnnouncementsNxera trims RSU share issuance after partial forfeiture5M ago
Company AnnouncementsNxera Pharma Spins Out Non-Core GPCR Program in NewCo Licensing and Series A Deal5M ago
Company AnnouncementsNxera Pharma Returns to Profit on Surging Q1 Revenue, Keeps 2026 Guidance Unchanged6M ago
Company AnnouncementsNxera Pharma Posts Strong Q1 2026 Momentum on Asia-Pacific Deals and Milestones6M ago

Nxera Pharma Secures Third AbbVie Milestone in Neurology Collaboration

Company AnnouncementsNxera Pharma Secures Third AbbVie Milestone in Neurology Collaboration6M ago

Company AnnouncementsNxera Pharma Issues New Shares to Fund Japan Employee Stock Plan and Expand RSU Program6M ago

Company AnnouncementsNxera Wins Taiwan Approval for QUVIVIQ Insomnia Drug, Eyes 2026 Launch6M ago